ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,035.69
      -1.57%
      US Tech 100
      16,926.80
      -2.21%
      Dow Jones
      37,815.92
      -1.49%
      Brent Oil
      85.505
      -0.45%
      Bitcoin
      59,189.34
      -2.31%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU
      6. Crossject (ALCJ)

      7. Crossject (ALCJ) News

      ALCJ

      Crossject (ALCJ)

      Crossject
      		Date:
      Sort by:
       Showing the most relevant articles for your search:EU:ALCJ
      DateTimeSourceHeadlineSymbolCompany
      12:53PMiHub NewswireFeaturedCannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia
      04/30/20241:05PMGlobeNewswire Inc.Crossject annonce le lancement d’une augmentation de capitalEU:ALCJCrossject
      04/25/20241:32AMGlobeNewswire Inc.Crossject reports audited financial results for 2023EU:ALCJCrossject
      04/25/20241:32AMGlobeNewswire Inc.Crossject communique ses résultats financiers audités pour 2023EU:ALCJCrossject
      04/25/20241:32AMGlobeNewswire Inc.Crossject reports audited financial results for 2023EU:ALCJCrossject
      04/10/202410:30AMGlobeNewswire Inc.Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital socialEU:ALCJCrossject
      04/02/202412:35PMGlobeNewswire Inc.Crossject trading on Euronext to resume as usual on Wednesday April 3EU:ALCJCrossject
      04/02/202412:35PMGlobeNewswire Inc.La cotation sur l’action de Crossject à Euronext reprendra comme d’habitude le mercredi 3 avrilEU:ALCJCrossject
      04/02/20244:30AMGlobeNewswire Inc.Crossject advances in its U.S. Strategy and reports Financial Results for 2023EU:ALCJCrossject
      04/02/20244:30AMGlobeNewswire Inc.Crossject advances in its U.S. Strategy and reports Financial Results for 2023EU:ALCJCrossject
      04/02/20244:30AMGlobeNewswire Inc.Crossject poursuit sa stratégie de développement aux États-Unis et publie ses résultats financiers pour 2023EU:ALCJCrossject
      03/08/20241:30AMGlobeNewswire Inc.Crossject gender equality score reaches 96/100 in 2024EU:ALCJCrossject
      03/08/20241:30AMGlobeNewswire Inc.Le Score de l’index Egalité femmes-hommes chez Crossject atteint 96/100 en 2024EU:ALCJCrossject
      03/08/20241:30AMGlobeNewswire Inc.Crossject gender equality score reaches 96/100 in 2024EU:ALCJCrossject
      02/27/20242:30AMGlobeNewswire Inc.Crossject obtains a financing up to €12 million, in two tranchesEU:ALCJCrossject
      02/27/20242:30AMGlobeNewswire Inc.Crossject obtains a financing up to €12 million, in two tranchesEU:ALCJCrossject
      02/27/20242:30AMGlobeNewswire Inc.Crossject obtient un financement jusqu’à 12 millions d’euros en 2 tranchesEU:ALCJCrossject
      02/06/202411:30AMGlobeNewswire Inc.Crossject publie une mise à jour stratégique de ses priorités pour 2024EU:ALCJCrossject
      02/06/202411:30AMGlobeNewswire Inc.Crossject provides strategic update on priorities for 2024EU:ALCJCrossject
      02/06/202411:30AMGlobeNewswire Inc.Crossject provides strategic update on priorities for 2024EU:ALCJCrossject
      02/01/202412:15PMGlobeNewswire Inc.Crossject to host a business briefing on commercial strategy on February 6 at 17:30 CETEU:ALCJCrossject
      02/01/202412:15PMGlobeNewswire Inc.Crossject organisera un webcast le 6 février à 17h30 pour faire le point sur sa stratégie commercialeEU:ALCJCrossject
      02/01/202412:15PMGlobeNewswire Inc.Crossject to host a business briefing on commercial strategy on February 6 at 17:30 CETEU:ALCJCrossject
      01/16/202411:15AMGlobeNewswire Inc.Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital socialEU:ALCJCrossject
      01/09/202410:21AMGlobeNewswire Inc.Crossject to present at Biotech Showcase on January 9 at 16:30 PTEU:ALCJCrossject
      01/09/202410:21AMGlobeNewswire Inc.Crossject annonce l’initiation de la couverture de son titre par ODDO BHFEU:ALCJCrossject
      01/09/202410:21AMGlobeNewswire Inc.Crossject to present at Biotech Showcase on January 9 at 16:30 PTEU:ALCJCrossject
      01/04/202412:00PMGlobeNewswire Inc.Crossject engage Syneos Health pour le lancement commercial du ZEPIZURE® aux États-UnisEU:ALCJCrossject
      01/04/202412:00PMGlobeNewswire Inc.Crossject engages Syneos Health for U.S. commercial launch of ZEPIZURE®EU:ALCJCrossject
      01/04/202412:00PMGlobeNewswire Inc.Crossject engages Syneos Health for U.S. commercial launch of ZEPIZURE®EU:ALCJCrossject
       Showing the most relevant articles for your search:EU:ALCJ